Purinergic signaling in giant cell formation

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 41-55

  Lemaire, Irma ^a   Falzoni, Simonetta ^b   Adinolfi, Elena ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Fusion; Inflammation; Macrophage; NFAT; Osteoclast; Polykarion; Review

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; PURINERGIC RECEPTOR;

ARTICLE; ASBESTOSIS; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL FUSION; CELL INTERACTION; CELL MATURATION; CROHN DISEASE; FOREIGN BODY; FOREIGN BODY REACTION; GIANT CELL; GIANT CELL ARTERITIS; GRANULOMA; GRANULOMATOUS INFLAMMATION; HUMAN; INFLAMMATION; LANGERHANS CELL HISTIOCYTOSIS; LEPROMATOUS LEPROSY; MACROPHAGE; MYELOID PROGENITOR CELL; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION; SILICOSIS; TH1 CELL; TH2 CELL; TUBERCULOSIS; ANIMAL; CYTOLOGY; METABOLISM; PATHOLOGY; REVIEW;

MAMMALIA;

ANIMALS; GIANT CELLS; HUMANS; INFLAMMATION; OSTEOCLASTS; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2X7;

EID: 84860864115     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e359     Document Type: Article

References (141)

1. Z Bar-Shavit: The osteoclast: a multinucleated, hematopietic-origin bone-resorbing osteoimmune cell. J Cell Biochem 102, 1130-1139 (2007)
2. T Negishi-Koga, H Takayanagi: Ca2+-NFATc1 signalling is an essential axis of osteoclast differentiation. Immunol Rev 231, 241-256 (2009)
3. T Wada, T Nakashima, N Hiroshi, JM Penninger: RANKL-RANK signalling in osteoclastogenesis and bone disease. Trends Mol Med 12, 17-25 (2006)
4. E Rubin, F Gorstein, R Rubin, R Schwarting, D Strayer: Rubin's Pathology: Clinicopathologic Foundations of Medicine, 4th edition. Lippincott Williams & Wilkins USA (2005)
5. M Yagi, T Miyamoto, Y Toyama, T Suda. Role of DCSTAMP in cellular fusion of osteoclasts and macrophage giant cells. J Bone Miner Metab 24, 355-358 (2006)
6. S Gordon, PR Taylor: Monocyte and macrophage heterogeneity. Nat Rev Immunol 5, 953-964 (2005)
7. CD Mills, K Kincaid, JM Alt, MJ Heilman, AM Hill: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164, 6166-6173 (2000)
8. NA Siciliano, JA Skinner, MH Yuk: Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177, 7131-7138 (2006)
9. ND Savage, T de Boer, KV Walburg, SA Joosten, K van Meijgaarden, A Geluk, TH Ottenhoff: Human antiinflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol 181, 2220-2226 (2008)
10. A Vignery: Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 202, 337-340 (2005)
11. RS Cotran, V Kumar, SL Robbins: Pathologic Basis of Diseases, Philadelphia, PA: Saunders, 51-92 (1994)
12. RI Enelow, GW Sullivan, HT Carper, GL Mandell: Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferongamma: comparison with other stimulating factors. Am J Respir Cell Mol Biol 6, 57-62 (1992)
13. AK McNally, JM Anderson: Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. J Pathol 147, 1487-1499 (1995)
14. HJ van der Rhee, W Hillebrands, WT Daems: Are Langhans giant cells precursors of foreign-body giant cells? Arch Dermatol Res 263, 13-21 (1978)
15. DO Adams: The granulomatous inflammatory response. Am J Pathol 84, 164-191 (1976)
16. MT Quinn, IA Sheptekin: Role of NADPH oxidase in formation and function of multinucleated giant cells. J Innate Immunol 6, 509-526 (2009)
17. T Langhans: Ueber Riesenzellen mit wandstandigen Kernen in Tuberkeln und die fibrose Forn des Tuberkels. Virchows Arch Pathol Anat 42, 383-404 (1868)
18. KA McDonough, Y Cress, BR Bloom: Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 61, 2763-2773 (1993)
19. OD Co, HL Hogan, S Kim, M Sandor: Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clinical Immunol 113, 130-136 (2004)
20. J Pieters: Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host and Microbe 3, 399-407 (2008)
21. JL Flynn, J Chan: Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15, 450-455 (2003)
22. J Chan, JL Flynn: The immunological aspects of latency in tuberculosis. Clin Immunol 110, 2-12 (2004)
23. G Lay, Y Poquet, P Salek-Peyron, MP Puissegur, C Botanch, H Bon, F Levillain, JL Duteyrat, JF Emile, F Altare: Langhans giant cells from M tubercolosis. Induced granulomas cannot mediate mycobacterial uptake. J Pathos 211, 76-85 (2007)
24. TA Wynn: Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol 4, 583-594 (2004)
25. CM Li, SJ Campbell, DS Kumararatne, R Bellamy, C Ruwende, KP McAdam, AV Hill, DA Lammas: Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis 186, 1458-1462 (2002)
26. SL Fernando, BM Saunders, R Sluyter, KK Skarratt, JS Wiley, WJ Britton: Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J Infect Dis 192, 149-155 (2005)
27. P Chiozzi, JM Sanz, D Ferrari, S Falzoni, A Aleotti, GN Buell, G Collo, F Di Virgilio: Spontaneous cell fusion in macrophages cultures expressing high levels of the P2Z/P2X7 receptor. J Cell Biol 138, 697-706 (1997)
28. S Anderson, VL Shires, RA Wilson, AP Mountford: In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol 28, 2827-2838 (1998)
29. S Anderson, VL Shires, RA Wilson, AP Mountford: Formation of multinucleated giant cells in the mouse lung is promoted in the absence of interleukin-12. Am J Respir Cell Mol Biol 20, 371-378 (1999)
30. ML Burke, MK Jones, GN Gobert, YS Li, MK Ellis, DP McManus: Immunopathogenesis of human schistosomiasis. Parasite Immunol 31, 163-176 (2009)
31. CE da Costa, NE Annels, CM Faaij, RG Forsyth, PC Hogendoorn, RM Egeler: Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cells histiocytosis. J Exp Med 201, 687-693 (2005)
32. F Coury, N Annels, A Rivollier, S Olsson, A Santoro, C Speziani, O Azocar, M Flacher, S Djebali, J Tebib, M Brytting, RM Egeler, C Rabourdin-Combe, JI Henter, M Arico, C Delprat: Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14, 81-87 (2008)
33. S Helming, S Gordon: The molecular basis of macrophage fusion. Immunobiology 212, 785-793 (2008)
34. NE Roche, JW Fulbright, AD Wagner, GG Hunder, JJ Goronzy, CM Weyand: Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36, 1286-1294 (1993)
35. W Rahman, FZ Rahman: Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol 50, 415-428 (2005)
36. E Nordborg, C Nordborg: Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford) 42, 413-421 (2003)
37. H Nunes, P Soler, D Valeyre: Pulmonary sarcoidosis. Allergy 60, 565-582 (2005)
38. D Gupta, R Agarwal, AN Aggarwal, SK Jindal: Molecular evidence for the role of mycobacteria in sarcoidosis: a meta analysis. Eur Respir J 30, 508-516 (2007)
39. DR Moller: Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16, 24-31 (1999)
40. A Bergeron, M Bonay, M Kambouchner, D Lecossier, M Riquet, P Soler, A Hance, A Tazi: Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 159, 3034-3043 (1997)
41. H Okamoto, K Mizuno, T Horio: Monocyte-derived multinucleated giant cells and sarcoidosis. J Dermatol Sci 31, 119-128 (2003)
42. K Mizuno, H Okamoto, T Horio: Inhibitory influences of xanthine inhibitor and angiotensin I-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol 150, 205-210 (2004)
43. K Mizuno, H Okamoto, T Horio: Heightened ability of monocytes from sarcoidosis patients to form multinucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 126, 151-156 (2001)
44. WG Brodbeck, JM Anderson: Giant cell formation and function. Curr Opin Hematol 16, 53-57 (2009)
45. T Takemura, WN Rom, VJ Ferrans, RG Crystal: Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particles. Am Rev Respir Dis 140, 1674-1685 (1989)
46. I Lemaire: Selective differences in macrophage populations and monokine production in resolving pulmonary granuloma and fibrosis. Am J Pathol 138, 487-495 (1991)
47. I Lemaire, PG Dionne, D Nadeau, J Dunnigan: Rat lung reactivity to natural and man-made fibrous silicates following short-term exposure. Environ Res 48, 193-210 (1989)
48. I Lemaire: Silica- and asbestos-induced pulmonary fifbosis. In: Lung biology in health and disease, Vol 80 Pulmonary fibrosis. Eds: Phan s.H., Thrall R.S., Marcel Dekker, New York (1995)
49. L Helming, S Gordon: Molecular mediators of macrophage fusion. Trends Cell Biol 19, 514-522 (2009)
50. S Falzoni, M Munerati, D Ferrari, S Spisani, S Moretti, F Di Virgilio: The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95, 1207-1216 (1995)
51. AN Shermon, R Sluyter, SL Fernando, AL Clarke, LP Dao-Ung, KK Skarralt, BM Saunders, KS Tan, BJ Gu, SJ Fuller, WJ Britton, S Petrou, JS Wiley: A Thr 357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281, 2079-2086 (2006)
52. DT Luttikhuizen, MC Harmsen, LF de Leij, MJ van Luyn: Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317, 289-298 (2004)
53. I Lemaire, N Leduc: Characterization of purinergic P2X7 receptor function in lung alveolar macrophages: bidirectional regulation by Th1/Th2 cytokines. Drug Dev Res 59, 118-127 (2003)
54. I Lemaire, S Falzoni, N Leduc, B Zhang, P Pellegatti, E Adinolfi, P Chiozzi, F Di Virgilio: Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells. J Immunol 177, 7257-7265 (2006)
55. A Gartland, KA Buckley, RA Hipskind, MJ Perry, JH Tobias, G Buell, I Chessell, WB Bowler, JA Gallagher: Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit Rev Eukaryot Gene Expr 13, 243-253 (2003)
56. TH Steinberg, JF Hiken: P2 receptors in macrophage fusion and osteoclast formation. Purinergic Signal 3, 53-57 (2007)
57. E Adinolfi, MG Callegari, D Ferrari, C Bolognesi, M Minelli, MR Wieckowski, P Pinton, R Rizzuto, F Di Virgilio: Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 16, 3260-3272 (2005)
58. E Adinolfi, MG Callegari, M Cirillo, P Pinton, C Giorgi, D Cavagna, R Rizzuto, F Di Virgilio: Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis. J Biol Chem 284, 10120-10128 (2009)
59. E Adinolfi, M Cirillo, R Woltersdorf, S Falzoni, P Chiozzi, P Pellegatti, MG Callegari, D Sandona, F Markwardt, G Schmalzing, F Di Virgilio: Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J 24, 3393-3404 (2010)
60. P Pellegatti, S Falzoni, P Pinton, R Rizzuto, F Di Virgilio: A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol Biol Cell 16, 3659-3665 (2005)
61. A Piccini, S Carta, S Tassi, D Lasiglié, G Fossati, A Rubartelli: ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 105, 8067-8072 (2008)
62. U Schenk, AM Westendorf, E Radaelli, A Casati, M Ferro, M Fumagalli, C Verderio, J Buer, E Scanziani, F Grassi: Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1, ra6 (2008)
63. S Falzoni, P Chiozzi, D Ferrari, G Buell, F Di Virgilio: P2X(7) receptor and polykarion formation. Mol Biol Cell 11, 3169-3176 (2000)
64. OR Baricordi, D Ferrari, L Melchiorri, P Chiozzi, S Hanau, E Chiari, M Rubini, F Di Virgilio: An ATPactivated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87, 682-690 (1996)
65. MC Hyman, D Petrovic-Djergovic, SH Visovatti, H Liao, S Yanamadala, D Bouïs, EJ Su, DA Lawrence, MJ Broekman, AJ Marcus, DJ Pinsky: Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 119, 1136-1149 (2009)
66. G Beldi, Y Wu, Y Banz, M Nowak, L Miller, K Enjyoji, A Haschemi, GG Yugutkin, D Candinas, M Exley, SC Robson: Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 48, 841-852 (2008)
67. AB Mackenzie, MT Young, E Adinolfi, A Surprenant: Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 280, 33968- 33976 (2005)
68. S Alloisio, R Aiello, S Ferroni, M Nobile: Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Mol Pharmacol 69, 1975-1983 (2006)
69. T Takenouchi, M Sato, and H Kitani: Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J Neurochem 102, 1518-1532 (2007)
70. AD Michel, E Fonfria: Agonist potency at P2X7 receptors is modulated by structurally diverse lipids. Br J Pharmacol 152, 523-537 (2007)
71. A MacKenzie, HL Wilson, E Kiss-Toth, SK Dower, RA North: Rapid secretion of interleukin-1 B by microvesicle shedding. Immunity 8, 825-835 (2001)
72. D Ferrari, C Pizzirani, S Gulinelli, MG Callegari, P Chiozzi, M Idzko, E Panther, F Di Virgilio: Modulation of P2X7 receptor functions by polymyxin B: crucial role of the hydrophobic tail of the antibiotic molecule. Br J Pharmacol 150, 445-454 (2007)
73. D Ferrari, C Pizzirani, E Adinolfi, S Forchap, B Sitta, L Turchet, S Falzoni, M Minelli, R Baricordi, F Di Virgilio: The Antibiotic Polymyxin B Modulates P2X7 Receptor Function. J Immunol 173, 4652-4660 (2004)
74. L Tomasinsig, C Pizzirani, B Skerlavaj, P Pellegatti, S Gulinelli, A Tossi, F Di Virgilio, M Zanetti: The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem 283, 30471-30481 (2008)
75. I Lemaire, H Yang, W Lauzon, N Gendron: M-CSF and GM-CSF promote alveolar macrophage differentiation into multinucleated giant cells with distinct phenotypes. J Leukoc Biol 60, 509-518 (1996)
76. I Lemaire, H Yang, V Lafond, J Dornand, T Commes, MF Cantin: Differential effects of macrophageand granulocyte-macrophage colony stimulating factors on cytokine gene expression during rat alveolar macrophage differentiation into multinucleated giant cells (MGC). J Immunol 157, 5118-5125 (1996)
77. C Mantel, Z Luo, HE Broxmeyer: Synergistic induction of phospholipid metabolism by granulocytemacrophage colony stimulating factor and steel factor in human growth factor-dependent cell line, M07e. Lipids 30, 641-647 (1995)
78. S Hong, N Schwarz, A Brass, M Seman, F Haag, F Koch- Nolte, WP Schilling, GR Dubyak: Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J Immunol 183, 578-592 (2009)
79. JO Jackson, R Longnecker: Re-evaluating Herpes Simplex Virus Hemifusion. J Virol [Epub ahead of print] (2010)
80. B Harmon, N Campbell, L Ratner: Role of Abl kinase and the Wave2 signalling complex in HIV-1 entry at a posthemifusion step. PLoS Pathog 6, e1000956 (2010)
81. K Rochlin, S Yu, S Roy, MK Baylies: Myoblast fusion: When it takes more to make one. Dev. Biol 341, 66- 83 (2010)
82. JF Hiken, TH Steinberg: ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells. Am J Physiol Cell Physiol 287, C403-C412 (2004)
83. M Monif, CA Reid, KL Powell, ML Smart, DA Williams: The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29, 3781-3791 (2009)
84. A Sapir, J Choi, E Leikina, O Avinoam, C Valansi, LV Chernomordik, AP Newman, B Podbilewicz: AFF-1, a FOS-1-regulated fusogen, mediates fusion of the anchor cell in C. elegans. Dev Cell 12, 683-698 (2007)
85. JI Elliott, A Surprenant, Marelli- FM Berg, JC Cooper, RL Cassady-Cain, C Wooding, K Linton, DR Alexander, CF Higgins: Membrane phospatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7, 808-816 (2005)
86. Y Qu, GR Dubyak: P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal 5, 163-173 (2007)
87. M Das, B Xu, L Lin, S Chakrabarti, V Shivaswamy, NS Rote: Phosphatidylserine efflux and intercellular fusion in a BeWo model human villous cytotrophoblast. Placenta 25, 396-407 (2004)
88. RB Driesen, GD Dispersyn, FK Verheyen, SM van den Eijnde, L Hofstra, F Thoné, P Dijkstra, W Debie, M Borgers, FC Ramaekers: Partial cell fusion: a newly recognized type of communication between dedifferentiating cardiomyocytes and fibroblasts. Cardiovasc Res 68, 37-46 (2005)
89. SM Van den Eijnde, MJB van den Hoff, CPM Reutelingsperger, WL van Heerde, MER Henfling, C Vermeij-Keers, B Schutte, M Borgers, FCS Ramaekers: Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci 114, 3631-3642 (2001)
90. L Helming, J Winter, S Gordon: The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci 122, 453-459 (2009)
91. P Pelegrin, A Surprenant: Pannexin-1 mediates large pore formation and interleukin-1B release by the ATPgated P2X7 receptor. EMBO J 25, 5071-5082 (2006)
92. S Locovei, E Scemes, F Qiu, DC Spray, G Dahl: Pannexin 1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Letters 581, 463-488 (2007)
93. GR Dubyak: Both sides now: multiple interactions of ATP with pannexin-1 hemichannels. Focus on "A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP". Am J Physiol Cell Physiol 296, C235-C241 (2009)
94. F Qiu, G Dahl: A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am J Physiol Cell Physiol 296, C250-C255 (2009)
95. S Penuela, R Bhalla, XQ Gong, KN Cowan, SJ Celetti, BJ Cowan, D Bai, Q Shao, DW Laird: Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci 120, 3772-3783 (2007)
96. FSA Fortes, IL Pecora, PM Persechini, S Hurtado, V Costa, R Coutinho-Silva, MB Braga, FC Silva-Filho, RC Bisaggio, FP De Farias, E Scemes, AC De Carvalho, RC Goldenberg: Modulation of intercellular communication in macrophages: possible interactions between GAP junctions and P2 receptors. J Cell Sci 117, 4717-4726 (2004)
97. JL Frendo, L Cronier, G Bertin, J Guibourdenche, M Vidaud, D Evain-Brion, A Malassiné : Involvement of connexin 43 in human trophoblast cell fusion and differentiation. J Cell Sci 116, 3413-3421 (2003)
98. K Herde, S Hartmann, R Brehm, O Kilian, C Heiss, A Hild, V Alt, M Bergmann, R Schnettler, S Wenisch: Connexin 43 expression of foreign body giant cells after implantation of nanoparticulate hydroxyapatite. Biomat 28, 4912-4921 (2007)
99. M Kim, LH Jiang, HL Wilson, RA North, A Surprenant: Proteomic and functional evidence for a P2X7 receptor signaling complex. EMBO J 20, 6347-6358 (2001)
100. MP Kuehnel, M Reiss, PK Anand, I Treede, D Holzer, E Hoffmann, M Klapperstueck, TH Steinberg, F Markwardt, G Griffiths: Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation. J Cell Sci 122, 505-512 (2009)
101. BJ Gu, C Rathsam, L Stokes, AB McGeachie, JS Wiley: Extracellular ATP dissociates nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore formation. Am J Physiol Cell Physiol 297, C430-C439 (2009)
102. JT Merrill, C Shen, D Schreibman, D Coffey, O Zakharendo, R Fisher, RG Lahita, J Salmon, BN Cronstein: Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 40, 1308-1315 (1997)
103. FM Kara, V Chitu, J Sloane, M Axelrod, BB Fredholm, ER Stanley, BN Cronstein: Adenosine A1 receptor (A1Rs) play a critical role in osteoclast formation and function. FASEB J 24, 2325-2333 (2010)
104. SK Banerjee, HWJ Young, JB Volmer, MR Blackburn: Gene expression profiling in inflammatory airway disease associated with elevated adenosine. Am J Physiol Lung Cell Mol Physiol 282, L169-L182 (2002).
105. W He and B Cronstein. The roles of adenosine and adenosine receptors in bone remodeling. Front Biosc. This issue.
106. JP Reyes, SM Sims, SJ Dixon: P2 receptor expression, signaling and function in osteoclasts. Front Biosc. This issue.
107. I Orriss, S Syberg, N Wang, B Robaye, A Gartland, N Jorgensen, T Arnett, JM Boeynaems. Bone phenotypes displayed by P2 receptor knockout mice. Front Biosc. This issue.
108. LN Naemsch, SJ Dixon, SM Sims: Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J Biol Chem 276, 39107-39114 (2001)
109. A Hoebertz, A Townsend-Nicholson, R Glass, G Burnstock, TR Arnett: Expression of P2 receptors in bone and cultured bone cells. Bone 27, 503-510 (2000).
110. AF Weidema, SJ Dixon, SM Sims: Activation of P2Y but not P2X(4) nucleotide receptors causes elevation of [Ca2+]i in mammalian osteoclasts. Am J Physiol Cell Physiol 280, C1531-C1539 (2001)
111. A Surprenant, F Rassendren, E Kawashima, RA North, G Buell: The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738 (1996)
112. A Gartland, KA Buckley, WB Bowler, JA Gallagher: Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 73, 361-369 (2003)
113. F Bianco, S Ceruti, A Colombo, M Fumagalli, D Ferrari, C Pizzirani, M Matteoli, F Di Virgilio, MP Abbracchio, C Verderio: A role for P2X7 receptor in microglial proliferation. J Neurochem 99, 745-758 (2006)
114. E Adinolfi, L Melchiorri, S Falzoni, P Chiozzi, A Morelli, A Tieghi, A Cuneo, G Castoldi, F Di Virgilio, OR Baricordi: P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99, 706-708 (2002)
115. J Kim, J Daewon, HK Kang, SY Jung, SS Kang, BM Min: Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem 20, 935-946 (2007)
116. HB Kwak, BK Lee, J Oh, JT Yeon, SW Choi, HJ Cho, MS Lee, JJ Kim, JM Bae, SH Kim, HS Kim: Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANL-induced c-fos and NFATc1 expression. Bone 46, 724-731 (2010)
117. SY Ryu, PM Peixoto, JH Won, DI Yule, KW Kinnally: Extracellular ATP and P2Y2 receptors mediate intercellular Ca(2+) waves induced by mechanical stimulation in submandibulr gland cells: role of mitochondrial regulation of store operated Ca(2+) entry. Cell Calcium 47, 65-76 (2010)
118. D Ferrari, C Stroh, K Schulze-Osthoff: P2X7/P2Z purino-receptor-mediated activation of transcription factor NFAT in microgliar cells. J Biol Chem 274, 13205-13210 (1999)
119. J Nilsson, LM Nilsson, YW Chen, JD Molkentin, D Erlinge, MF Gomez: High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26, 794-800 (2006)
120. S Ryzhov, AE Goldstein, I Biaggioni, I Feoktistov: Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Mol Pharmacol 70, 727-735 (2006)
121. T Woehrle, L Yio, A Elkhal, Y Sumi, Y Chen, Y Yao, PA Insel, WG Junger: Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T cell activation at the immune synapse. Blood Prepublished online (2010)
122. Q Zhao, X Wang, Y Liu, A He, R Jia: NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 42, 576- 579 (2010)
123. l Yip, T Woehrle, R Corriden, M Hirsh, Y Chen, Y Inoue, V Ferrari, PA Insel, WG Junger: Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 23, 1685-1693 (2009)
124. A Kataoka, H Tozaki-Saitho, Y Koga, M Tsuda, K Inoue: Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J Neurochem 108, 115-125 (2009)
125. H Takayanagi, S Kim, T Koga, H Nishina, M Isshiki, H Yoshida, S Saiura, M Isobe, T Yokochi, J Inoue, EF Wagner, TW Mak, T Kodama, T Taniguchi, M Matsumoto: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 (2002)
126. AO Aliprantis, Y Ueki, R Sulyanto, A Park, KS Sigrist, SM Sharma, MC Ostrowski, BR Olsen, LH Glimcher: NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Cell Biol 161, 945-956 (2003)
127. L Sun, Y Peng, N Zaidi, LL Zhu, J Iqbal, K Yamoah, X Wang, P Liu, E Abe, BS Moonga, S Epstein, M Zaidi: Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am J Physiol Renal Physiol 292, F285-F291 (2007)
128. TN Crotti, M Flannery, NC Walsh, JD Fleming, SR Goldring, KP McHugh: NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. Gene 372, 92-102 (2006)
129. K Kim, SH Lee, J Ha Kim, Y Choi, N Kim: NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DCSTAMP). Mol Endocrinol. 22, 176-185 (2008)
130. A Agrawal, KA Buckley, K Bowers, M Furber, JA Gallagher, A Gartland: The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro. Purinergic Signal Epub 2010 21 (2010)
131. SD Ohlendorff, CL Tofteng, J-EB Jensen, S Petersen, R Civitelli, M Fenger, B Abrahamsen, AP Hermann, P Eiken, NR Jørgensen: Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect estrogen treatment. Pharmacogenet Genom17, 555-67 (2007)
132. A Nicke, YH Kuan, M Masin, J Rettinger, B Marquez-Klaka, O Bender, DC Gorecki, RD Murrell- Lagnado, F Soto: A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock out mice. J Biol Chem 284, 25813-25822 (2009)
133. J Korcok, LN Raimundo, X Du, SM Sims, SJ Dixon. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem 280, 16909- 16915 (2005)
134. KL Abbott, JR 2nd Loss, AM Robida, TJ Murphy. Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. Mol Pharmacol 58, 946-953 (2000)
135. KL Abbott, AM Robida, ME Davis, GK Pavlath, JM Camden, JT Turner, TJ Murphy: Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors. J Mol Cell Cardiol 32, 391-403 (2000)
136. J Nilsson, LM Nilsson, YW Chen, JD Molkentin, D Erlinge, MF Gomez: High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26, 794-800 (2006)
137. L Erb, J Liu, J Ockerhausen, Q Kong, RC Garrad, K Griffin, C Neal, B Krugh, LI Santiago-Perez, FA Gonzales, HD Gresham, JT Turner, GA Weisman. An RGD sequence in the P2Y(2) receptor interacts with alpha(v)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol 153, 491-501 (2001)
138. R Saxena, G Pan, JM McDonald: Osteoblast and osteoclast differentiation in modeled microgravity. Ann N Y Acad Sci 1116, 494-498 (2007)
139. E Adinolfi, M Kim, MT Young, F Di Virgilio, A Surprenant: Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem 278, 37344-37351 (2003)
140. JT Price, JM Quinn, NA Sims, J Vieusseux, K Waldeck, SE Docherty, D Myers, A Nakamura, MC Waltham, MT Gillespie, EW Thompson: The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 65, 4929-4938 (2005)
141. A Yano, S Tsutsumi, S Soga, MJ Lee, J Trepel, H Osada, L Neckers: Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proc Natl Acad Sci USA 105, 15541-15546 (2008)